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Abstract
While most cancer studies focused on patient variations lying in protein-coding regions, 
the noncoding ~98% of the genome, containing cis-regulatory regions that control when 
and where genes are expressed, is largely unexplored. Transcription factors are key 
proteins binding to cis-regulatory regions to modulate the rate of gene transcription. 
Delineating the specific positions at which a TF binds DNA is of high importance in 
deciphering gene regulation. As cancer is a disease of disrupted cellular regulation, it 
is critical to analyze these regions to highlight patient somatic  mutations altering the 
gene regulatory program of the cells.  I will present our recent works on the evalua-
tion of the  combined effects of transcriptional and post-transcriptional dysregulation 
of gene expression. Our analyses  culminated with the identification of mutations at 
TFBSs affecting the expression of key protein-coding and miRNA  genes with a casca-
ding dysregulating effect of the cells’ regulatory program. Our predictions were enriched 
for  protein-coding and miRNA genes previously annotated as potential cancer drivers. 
Functional enrichment analyses  highlighted the dysregulation of key pathways asso-
ciated with carcinogenesis. These results confirm that our method  predicts cis-regula-
tory mutations related to the dysregulation of key gene regulatory networks in cancer 
12 Severo Ochoa Research Seminar - BSC 
2019-2020
patients. This  new strategy represents an original methodology to decipher how the 
gene regulatory program is disrupted in  cancer cells by combining transcriptional and 
post-transcriptional regulation of gene expression.
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